English | Español

Glaxosmithkline
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Carol Ostrow | Dec 16, 2017

Multiple myeloma study results encouraging, GSK says
Carol Ostrow | Dec 15, 2017

GSK receives FDA approval for expanded use of Nucala
Carol Ostrow | Dec 15, 2017

GSK says Shingrix promising for preventing shingles in stem cell transplant patients
Carol Ostrow | Sep 24, 2017

GlaxoSmithKline, Innoviva COPD therapy gains FDA approval
Carol Ostrow | Sep 23, 2017

Self-injectable form of Lupus therapy clears hurdle in Europe
Carol Ostrow | Sep 21, 2017

GSK’s Shingrix shingles vaccine clears an FDA hurdle

Carol Ostrow | Sep 18, 2017

Salford Lung Study shows promise for GlaxoSmithKline asthma treatment

Trending
Patient Daily | Sep 30, 2025

USC Keck medical graduate Melody Glenn and residency alum Brian Lee reflect physician presence in Phoenix area
+ Pharmaceuticals
Patient Daily | Sep 25, 2025

NIH awards Baylor College of Medicine $15 million for rare diseases consortia
+ Pharmaceuticals
Patient Daily | Oct 2, 2025

National health organizations call for passage of SOAR Act on World Oxygen Day
+ Pharmaceuticals
Patient Daily | Oct 2, 2025

Texas Medical Center receives NIH grant for kidney, urologic, hematologic research training